Michael T. Lawton, MD, is president and CEO of Barrow Neurological Institute. (Provided photo)
(Disclosure: Rose Law Group Founder and President Jordan Rose is a member of the Barrow Neurological Foundation Board of Trustees and is co-chair of the technology committee.)
By AZ Business Magazine
Barrow Neurological Institute has officially opened a new cutting-edge research center that is expected to revolutionize neurological research and expand Phoenix’s research footprint into the areas of environmental neurology and health equity. The Barrow Neuro Analytics Center, located at the Park Central property in the Phoenix Medical Quarter, comprises a 10,099 square-foot dry laboratory housing 10 principal research investigators and their dedicated teams.
These experts delve into critical areas such as environmental epidemiology, advanced neuroimaging, global health, neurological drug development, health equity, and data science. Research at the center will span a wide spectrum of neurological diseases, including Alzheimer’s, Parkinson’s, ALS, stroke, Multiple Sclerosis, and epilepsy. The center, which held a grand opening celebration on May 22, is poised to revolutionize neurological research and foster interdisciplinary collaboration.
“This center represents a new concept in clinical neuroscience research. Our collaborative approach will accelerate breakthroughs and elevate Phoenix’s status as a hub of medical discovery,” says Brad Racette, MD, FAAN, Chairman of Neurology and Senior Vice President at Barrow Neurological Institute.
